Fast-Tracking the Future

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

The Future of Specialty Medicine

In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian […]

Reducing Polypharmacy in Older Adults

Image Credit: Adobe Stock Images/Kotchakorn.com Among the older population, polypharmacy—the use of five or more medications—has skyrocketed. The issue lies in the fact that some […]